Topical steroid withdrawal diagnostic criteria defined by NIH researchers

News Healthcare & Pharma Guidance

Date: 14th Mar, 2025 Source: National Institutes of Health (NIH) Country: USA Original Source

Brief

"On Friday, March 14, 2025, the National Institutes of Health (NIH) issued an update regarding Topical steroid withdrawal diagnostic criteria defined by NIH researchers. Researchers at NIH determined that dermatitis resulting from topical steroid withdrawal is distinct from eczema and caused by excess NAD+, a form of vitamin B3, identifying treatments to lower its levels for potential clinical trials."

This content is restricted.

Highlights content goes here...

This content is restricted.

National Institutes of Health (NIH)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Topical steroid withdrawal diagnostic criteria defined by NIH researchers

Brief

National Institutes of Health (NIH)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Topical steroid withdrawal diagnostic criteria defined by NIH researchers

Brief

National Institutes of Health (NIH)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.